|
Hepion Pharmaceuticals, Inc. (HEPA) Avaliação DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Hepion Pharmaceuticals, Inc. (HEPA) Bundle
Procurando avaliar o valor intrínseco da Hepion Pharmaceuticals, Inc.? Nossa calculadora DCF (HEPA) integra dados do mundo real com extensos recursos de personalização, permitindo otimizar suas previsões e aprimorar suas opções de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -7.7 | -20.1 | -30.3 | -43.5 | -49.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .0 | .0 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -7.8 | -20.1 | -30.4 | -43.6 | -49.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 13.9 | 40.7 | 91.3 | 51.2 | 14.8 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .5 | 3.7 | 2.4 | 2.7 | 2.3 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.1 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0.82907 | 0.82907 | 0.82907 | 0.82907 | 0.82907 | 0.82907 | 0.82907 | 0.82907 | 0.82907 | 0.82907 |
| EBITAT | -6.9 | -20.2 | -30.4 | -40.8 | -48.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6.4 | -17.0 | -31.7 | -40.5 | -49.2 | -2.3 | .0 | .0 | .0 | .0 |
| WACC, % | 9.52 | 9.67 | 9.67 | 9.58 | 9.66 | 9.62 | 9.62 | 9.62 | 9.62 | 9.62 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -15 | |||||||||
| Equity Value | 12 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | 3.13 |
What You Will Get
- Comprehensive HEPA Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Intrinsic value and NPV are calculated automatically and in real-time.
- Scenario Analysis: Explore various scenarios to assess Hepion Pharmaceuticals' future performance.
- User-Friendly Interface: Designed for industry professionals while remaining easy to navigate for newcomers.
Key Features
- Customizable Clinical Parameters: Adjust essential metrics such as trial success rates, market potential, and R&D expenditures.
- Instant DCF Valuation: Provides immediate calculations for intrinsic value, NPV, and additional financial metrics.
- High-Precision Analysis: Leverages Hepion’s actual financial data for accurate valuation results.
- Effortless Scenario Testing: Evaluate various assumptions and analyze outcomes with ease.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the prebuilt Excel template with Hepion Pharmaceuticals' (HEPA) data included.
- Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Hepion Pharmaceuticals' intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose This Calculator for Hepion Pharmaceuticals, Inc. (HEPA)?
- All-in-One Solution: Features DCF, WACC, and comprehensive financial ratio analyses tailored for Hepion Pharmaceuticals.
- Flexible Parameters: Modify yellow-highlighted cells to explore different investment scenarios for (HEPA).
- In-Depth Analysis: Automatically computes Hepion’s intrinsic value and Net Present Value for informed decision-making.
- Preloaded Information: Historical and projected data provide reliable starting points for analysis.
- Expert Level: Perfect for financial analysts, investors, and consultants focusing on the biotechnology sector.
Who Should Use This Product?
- Pharmaceutical Students: Understand drug development processes and apply theoretical knowledge using real-world data.
- Researchers: Integrate advanced models into your studies or clinical trials.
- Investors: Evaluate your investment strategies and assess valuation outcomes for Hepion Pharmaceuticals, Inc. (HEPA).
- Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model.
- Healthcare Entrepreneurs: Discover how large biotech firms like Hepion are evaluated in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Hepion Pharmaceuticals, Inc. (HEPA).
- Real-World Data: Hepion's historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results specific to Hepion Pharmaceuticals, Inc. (HEPA).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.